Evidence map›Paper›PMID 40654651›Full record

ArticlebioRxiv : the preprint server for biology2025

GDF15 reprograms the microenvironment to drive the development of uveal melanoma liver metastases.

Sathya Neelature Sriramareddy, Navya Siddarajappa, Jun Sung Park, Thanh Nguyen, Jeffim N Kuznetsoff, Stefan Kurtenbach, James J Dollar, David J Adams, Jonathan D Licht, Zelia M Correa and 3 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Sathya Neelature SriramareddyThe Department of Tumor Microenvironment and Metastasis, The Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL, USA.
Navya SiddarajappaThe Department of Tumor Microenvironment and Metastasis, The Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL, USA.
Jun Sung ParkMedical Research Council (MRC) Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine (WIMM), John Radcliffe Hospital, University of Oxford, Oxford OX3 9DS, UK.
Thanh NguyenDepartment of Biostatistics, University of Utah, Salt Lake City, UT.
Jeffim N KuznetsoffDepartment of Ophthalmology and Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL.
Stefan KurtenbachDepartment of Ophthalmology and Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL.ORCID 0000-0002-7445-596X
James J DollarDepartment of Ophthalmology and Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL.
David J AdamsWellcome Sanger Institute, Hinxton, UK.
Jonathan D LichtUniversity of Florida Health Sciences Center, Gainesville, FL.
Zelia M CorreaDepartment of Ophthalmology and Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL.
Y Ann ChenDepartment of Biostatistics, University of Utah, Salt Lake City, UT.
J William HarbourDepartment of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX.ORCID 0000-0002-1104-9809
Keiran S M SmalleyThe Department of Tumor Microenvironment and Metastasis, The Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL, USA.ORCID 0000-0003-1089-9307

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI John L. Cleveland · 1998 to 2026
$93.5M
UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Sandi Leigh Pruitt · 2010 to 2026
$53.7M
University of Florida Health Cancer Center Support GrantP30CA247796 · NCI · UNIVERSITY OF FLORIDA · PI Stephanie A S Staras · 2023 to 2026
$10.9M
Stem Cell, Organoid and Cell Phenotyping ModuleP30EY030413 · NEI · UT SOUTHWESTERN MEDICAL CENTER · PI DANIELLE M. ROBERTSON · 2019 to 2026
$5.9M
Characterization and targeting of the epigenetic state underlying uveal melanoma liver metastasisR01CA256193 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI HARBOUR, JAMES WILLIAM, LICHT, JONATHAN D. · 2021 to 2025
$3.2M
NCI NIH HHS P30 CA076292NCI NIH HHS P30 CA142543NCI NIH HHS P30 CA247796NCI NIH HHS R01 CA256193NEI NIH HHS P30 EY030413
6 · The paper itself

Abstract

Uveal melanoma (UM) results in fatal liver metastasis, yet little is known about the interactions between UM and host cells in the tumor microenvironment that promote this distinctive proclivity. Here, we used single cell (sc)-RNA-Seq analysis of UM-hepatic stellate cell (HSC) co-cultures to demonstrate that HSCs enriched for UM cell states that expressed genes implicated in cell survival, metabolic reprogramming and angiogenesis. A lead candidate driver of HSC reprogramming was the TGF-β family member GDF15, which was associated with a metastatic UM phenotype. Silencing of BAP1 in UM cells led to increased GDF15 expression and accumulation of H3K27ac marks at the GDF15 promoter. Treatment of HSCs with GDF15 led to increased expression extracellular matrix proteins, inflammatory cytokines and angiogenic factors, including IL-8. Both exogenous GDF15, IL-8 and conditioned media from UM-HSC co-cultures increased endothelial cell network formation

Identifiers

PMID40654651
PMCPMC12247901

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.